Advertisement

In Vitro

, Volume 20, Issue 2, pp 119–126 | Cite as

Endogenous prostaglandin production by established cultures of neoplastic rat mammary epithelial cells

  • Leonard A. Cohen
  • Rashida A. Karmali
Article

Summary

The production and release of prostaglandins (PGs) into the growth medium by established cultures of neoplastic, mammary epithelial cells derived from (a)N-nitrosomethyl-urea (NMU)-induced and (b) 7,12-dimethylbenz(a) anthracene (DMBA)-induced mammary tumors, was assessed using radioimmunoassay techniques.

Prostaglandin production was determined, to a considerable extent, by in vitro conditions and the tumor line analyzed. In medium supplemented with bovine calf serum (10%), NMU cells synthesized and released nanogram quantities of PGF2, PGE1, and PGF (6.7, 4.7, and 1.7 ng/106 cells per 48 h, respectively). Concentrations of the two stable protanoid metabolites, 6-keto-PGF and TXB2, were indistinguishable from controls. In cells derived from the DMBA-induced tumor (RBA cells), no net production of immunoreactive PGs was detected. In contrast, in media supplemented with fetal bovine serum (10%), both RBA and NMU cells synthesized and released nanogram quantities of PGE2 (1 and 4 ng/106 cells per 48 h, respectively).

PGE2 production by both NMU and RBA cells was inhibited by ibuprofen, an inhibitor of cyclooxygenase (EC 1. 14. 99.1). The pattern of PG inhibition by ibuprofen differed in the two cell lines. In NMU cells, a linear dose-response inhibitory pattern was discernable, whereas in RBA cells a biphasic pattern was observed; PGE2 levels incresed at low concentration of ibuprofen and then decreased at higher concentration. At 100 μg/ml ibuprofen, PG synthesis and release was inhibited by 90 and 100% and cell growth by 64 and 66% in NMU and RBA cells, respecively. There was no obvinous dse-response relationship between ibuprofen concentration and cell growth inhibition in either cell line.

These results underline the importance of the serum component of growth medium when analyzing PG production in vitro and suggest that the epithelial cell components of experimental mammary tumors are capable of producing physiogically relevant amounts of PGs.

Key words

mammary tumor cell culture prostaglandin production 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Williams, E. D.; Karim, S. M. M.; Sandler, M. Prostaglandin secretion by medullary carcinoma of the thyroid. Lancet 1: 22–23; 1968.PubMedCrossRefGoogle Scholar
  2. 2.
    Bennett, A. Prostaglandins, tumor invasiveness and treatment with inhibitors of prostaglandin synthesis. Prog. Lipid Res. 20: 677–679; 1982.CrossRefGoogle Scholar
  3. 3.
    Karmali, R. A. Review: Prostaglandins and cancer. Prostaglandins Med. 5: 11–28; 1980.PubMedCrossRefGoogle Scholar
  4. 4.
    Powles, T. J.; Bockman, R. S.; Honn, K. V.; Ramwell, P. R. eds. Prostaglandins and cancer: Proc. 1st Conference on prostaglandins and cancer. New York: Alan R. Liss, Inc. 1982: 1–821.Google Scholar
  5. 5.
    Plescia, O. J. Does prostaglandin synthesis effectin vivo tumour growth by altering tumour/host balance? Proc. 1st Conference on prostaglandins and cancer. New York: Alan R. Liss, Inc.; 1982: 619–632.Google Scholar
  6. 6.
    Tashjian, A.; Voelkel, E. F.; Levine, L. Prostaglandins, tumor cells, and bone metabolism. Proc. 1st Conference on prostaglandins and cancer. New York: Alan R. Liss, Inc.; 1982: 513–524.Google Scholar
  7. 7.
    Bennett, A.; Berstock, D. A.; Raja, B.; Stamford, I. F. Survival time after surgery is inversely related to the amounts of prostaglandins extracted from human breast cancers. Br. J. Pharmacol. 66: 451P; 1979.Google Scholar
  8. 8.
    Rolland, P. H.; Martin, P. M.; Jacquemier, J.; Rolland, A.; Toga, M. Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J. Natl. Cancer Inst. 64: 1061–1070; 1982.Google Scholar
  9. 9.
    Karmali, R. A.; Welt, S.; Thaler, H. T.; LeFevre, F. Prostaglandins in breast cancer: Relationship to disease stage and hormone status. Proc. Int. Assoc. Breast Cancer Res. Denver, CO; 1983: Abstr. 136.Google Scholar
  10. 10.
    Bennett, A.; Houghton, J.; Leper, D. J.; Stamford, I. F. Cancer growth, response to treatment and survival time in mice: Beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen. Prostaglandins 12: 179–200; 1979.CrossRefGoogle Scholar
  11. 11.
    Bockman, R. S. Prostaglandin production by human blood monocytes and mouse peritoneal macrophages: Synthesis dependent onin vitro culture conditions. Prostaglandins 21: 9–31; 1981.PubMedCrossRefGoogle Scholar
  12. 12.
    Karmali, R. A.; Muse, P.; Allen, G.; Louis, T. Macrophage production of prostaglandins: Effects of fetal calf serum and diazepam. Use of an improved method for extracting 6-keto-PGF1. Prostagl. Leukotr. Med. 8: 565–577; 1982.Google Scholar
  13. 13.
    Cohen, L. A.; Tsuang, J.; Chan, P. C. Characteristics of rat normal mammary epithelial cells and DMBA-induced mammary adenocarcinoma cells grown in monolayer culture. In Vitro 10: 51–62; 1974.PubMedCrossRefGoogle Scholar
  14. 14.
    Cohen, L. A. Isolation and characterization of a serially cultivated, neoplastic, epithelial cell line from theN-nitrosomethylurea-induced rat mammary adenocarcinoma. In Vitro 18: 565–575; 1982.PubMedGoogle Scholar
  15. 15.
    Oyama, V. I.; Eagle, H. Measurement of cell growth in tissue culture with a phenol reagent (folin-ciocalteau). Proc. Soc. Exp. Biol. Med. 91: 305–307; 1963.Google Scholar
  16. 16.
    Karmali, R. A.; Sarkar, N. H.; Whittington, E.; Good, R. A. Prostaglandin regulation of murine mammary tumor virus production: A basis for some of the glucocorticoid and prolactin actions on mammary tumor cell cultures. Prostagl. Leukotr. Med. 9: 641–655; 1982.CrossRefGoogle Scholar
  17. 17.
    Karmali, R.; Thaler, H. T.; Cohen, L. A. Prostaglandin concentrations and prostaglandin synthetase activity inN-nitrosomethylurea-induced rat mammary adenocarcinoma. Eur. J. Cancer Clin. Oncol. 19: 817–823; 1983.PubMedCrossRefGoogle Scholar
  18. 18.
    Boone, C. W.; Mantel, N.; Caruso, T. D.; Kazam, E.; Stevenson, R. E. Quality control studies of fetal bovine serum used in tissue cultures. In Vitro 3: 174–189; 1972.Google Scholar
  19. 19.
    Milo, G. B.; Malarkey, W. B.; Powell, J. E.; Blakeslee, J. R.; Yohn, D. S. Effects of steroid hormones in fetal bovine serum on plating the cloning of human cells in vitro. In Vitro 12: 23–30; 1976.PubMedGoogle Scholar
  20. 20.
    Barnes, D.; Sato, G. Factors that stimulate proliferation of breast cancer cellsin vitro in serum-free medium. McGrath, C.; Brennan, M. J.; Rich, M. A. eds. Cell biology of breast cancer. New York: Academic Press, Inc.; 1980: 277–288.Google Scholar
  21. 21.
    Hong, S. L.; Patton, G.; Deykin, D. Arachidonic acid level in cellular lipids determines the amount of prostaglandins synthesized during cell growth in tissue culture. Prostaglandins 17: 53–58; 1979.PubMedCrossRefGoogle Scholar
  22. 22.
    Denning, G. M.; Figard, P. H.; Spector, A. A. Effect of fatty acid modification on prostaglandin production by cultured 3T3 cells. J. Lipid Res. 23: 584–596; 1982.PubMedGoogle Scholar
  23. 23.
    Wicha, M. S.; Liotta, L. A.; Kidwell, W. R. Effect of free fatty acids on the growth of normal and neoplastic rat mammary epithelial cells. Cancer Res. 39: 426–435; 1979.PubMedGoogle Scholar
  24. 24.
    Smith, F. B.; Kikkawa, Y.; Diglio, C. A.; Dalen, R. C. Increased saturated phospholipid in cultured cells grown with linoleic acid. In Vitro 18: 331–338; 1982.PubMedGoogle Scholar
  25. 25.
    Shen, T. Y. Prostaglandin synthetase inhibitors. Berti, F.; Samuelsson, B.; Velo, G. P. eds. Prostaglandins and thromboxanes. New York: Plenum Press; 1977: 111–136.Google Scholar
  26. 26.
    Flower, R. J. Drugs which inhibit prostaglandin biosynthesis. Pharmacol. Rev. 26: 33–66; 1974.PubMedGoogle Scholar
  27. 27.
    Owen, K.; Gomolka, D.; Droller, M. J. Production of prostaglandin E2 by tumor cellsin vitro. Cancer Res. 40: 3167–3171; 1980.PubMedGoogle Scholar
  28. 28.
    Hortobagyi, G. N.; Schultz, P.; Cailleau, R.; Samaan, N.; Blumenschein, G. In vitro prostaglandin production by metastatic breast cancer. Proc. 1st Conference on prostaglandins and cancer. New York: Alan R. Liss, Inc.; 1982: 567–572.Google Scholar
  29. 29.
    Johnson, G. S.; Pastan, I. Change in growth and morphology of fibroblasts by prostaglandins. J. Natl. Can. Inst. 47: 1357–1364; 1971.Google Scholar
  30. 30.
    Thomas, D. R.; Philpott, G. W.; Jaffe, B. M. The relationship between concentration of prostaglandin E and rates of cell replication. Exp. Cell Res. 84: 40–46; 1974.PubMedCrossRefGoogle Scholar
  31. 31.
    Jacobson, H. I. Oncolytic action of prostaglandins. Cancer Chemother. Rep. 58: 503–511; 1974.PubMedGoogle Scholar
  32. 32.
    Jubiz, W.; Frailey, J.; Smith, J. B. Inhibitory effect of prostaglandin F2Alpha on the growth of a hormone-dependent rat mammary tumor. Cancer Res. 39: 998–1000; 1979.PubMedGoogle Scholar
  33. 33.
    Narisawa, T.; Sato, M.; Tani, M.; Kudo, T.; Takahashi, T.; Goto, A. Inhibition of development of methylnitrosourea induced rat colon tumors by indomethacin treatment. Cancer 41: 1954–1957; 1981.Google Scholar
  34. 34.
    McCormick, D. L.; Moon, R. C. Indomethacin inhibits mammary carcinogenesis in rats. Proc. Int. Assoc. Breast Cancer Res. Denver, CO; 1983; Abstr. 74.Google Scholar
  35. 35.
    Carter, C. A.; Milholland, R. J.; Shea, W.; Ip, M. M. Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12-dimethylbenz(a)anthracene-induced, mammary tumorigenesis in rats fed different levels of fat. Cancer Res. 43: 3559–3562; 1983.PubMedGoogle Scholar

Copyright information

© Tissue Culture Assciation, Inc 1984

Authors and Affiliations

  • Leonard A. Cohen
    • 1
  • Rashida A. Karmali
    • 2
  1. 1.Naylor Dana Institute for Disease PreventionAmerican Health FoundationValhalla
  2. 2.Sloan-Kettering Institute for Cancer ResearchNew York

Personalised recommendations